Evidence map›Paper›PMID 37363600›Full record

ArticleAnnals of medicine and surgery (2012)2023

Lack of knowledge regarding the misuse of domperidone in Pakistan and its serious consequences: short communication.

Asifa Kalwar, Rabel Q Mangi, Junaid U Rehman, Sidhant Ochani, Muhammad Faraz, Sandhaya Kukreja, Md Al Hasibuzzaman

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Asifa KalwarDepartment of Medicine, Dow University of Health Sciences, Karachi.ORCID 0000-0003-2442-0037
Rabel Q MangiDepartment of Medicine, Dow University of Health Sciences, Karachi.
Junaid U RehmanDepartment of Medicine, Dow University of Health Sciences, Karachi.
Sidhant OchaniDepartment of Medicine, Khairpur Medical College, Khairpur Mir's.ORCID 0000-0003-2079-148X
Muhammad FarazDepartment of Medicine, Shaheed Mohtarma Benazir Bhutto Medical University, Larkana, Pakistan.
Sandhaya KukrejaDepartment of Medicine, Dow University of Health Sciences, Karachi.
Md Al HasibuzzamanInstitute of Nutrition and Food Science, University of Dhaka, Dhaka, Bangladesh.ORCID 0000-0003-0548-4836
Dow University of Health Sciences · PKShaheed Mohtarma Benazir Bhutto Medical University · PKUniversity of Dhaka · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Domperidone is an antagonist of the peripheral dopamine (D2) receptor. It works as an antiemetic by blocking D2-receptors at the chemoreceptor trigger zone and as a gastroprokinetic drug by blocking GI tract D2-receptors. According to research, using domperidone significantly raises the risk of cardiac arrhythmia and sudden cardiac death by 70%, most likely through prolonging the QT interval. Blockade of hERG voltage-gated potassium channels is thought to be the reason. Here in Pakistan, this drug is being prescribed by every other physician and even patients frequently self-medicate themselves with it. Due to the serious side effects of this medication, extreme caution should be exercised when prescribing it, especially to the elderly, those who have underlying QT prolongation, those taking medications known to prolong QT, and even more so in pregnant women as there is some evidence that domperidone crosses into breast milk in small amounts and causes an irregular heartbeat in the baby. At least we, on our part, can limit the usage of the drug only with a prescription and, where necessary, if not completely, stop it.

Indexed as

cardiovascular diseasesdomperidoneknowledgemisusePakistan

Identifiers

PMID37363600
PMCPMC10289668
OpenAlexW4376602632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.